⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7354141 | 0.78 | USP2 (0.46) | — | |
| SCHEMBL3581693 | 0.77 | CA1 (0.35) | — | |
| SCHEMBL11284503 | 0.76 | — | — | |
| SCHEMBL900920 | 0.76 | — | — | |
| SCHEMBL6578001 | 0.76 | — | — | |
| SCHEMBL4652322 | 0.76 | — | — | |
| SCHEMBL27455492 | 0.75 | USP2 (0.50) | — | |
| SCHEMBL3569833 | 0.74 | — | — | |
| SCHEMBL9643006 | 0.74 | — | — | |
| SCHEMBL7348117 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1112252-A4 | KAPPA AGONIST COMPOUNDS AND PHARMACEUTICAL FORMULATIONS THEREOF | ADOLOR CORP (US) | 2004-07-14 | — | — | EP | claimed |
| EP-1112252-A1 | KAPPA AGONIST COMPOUNDS AND PHARMACEUTICAL FORMULATIONS THEREOF | Adolor Corporation (US) | 2001-07-04 | — | — | EP | claimed |
| WO-2000014065-A1 | KAPPA AGONIST COMPOUNDS AND PHARMACEUTICAL FORMULATIONS THEREOF | ADOLOR CORPORATION (US) | 2000-03-16 | — | — | WO | claimed |
| WO-2024124084-A1 | METHODS OF ADMINISTERING BELUMOSUDIL FOR TREATMENT OF MULTIPLE MYELOMA | KADMON CORPORATION, LLC (US) | 2024-06-13 | — | — | WO | disclosed |
| WO-2024063770-A1 | LIQUID FORMULATION OF BELUMOSUDIL | KADMON CORPORATION, LLC (US) | 2024-03-28 | — | — | WO | disclosed |
| WO-2024064757-A1 | LIQUID FORMULATION OF BELUMOSUDIL | KADMON CORPORATION, LLC (US) | 2024-03-28 | — | — | WO | disclosed |
| WO-2024015067-A1 | METHODS OF ADMINISTERING BELUMOSUDIL FOR TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASE | KADMON CORPORATION, LLC (US) | 2024-01-18 | — | — | WO | disclosed |
| WO-2024015066-A1 | METHODS OF ADMINISTERING BELUMOSUDIL IN COMBINATION WITH CYP3A INDUCERS AND/OR PROTON PUMP INHIBITORS | KADMON CORPORATION, LLC (US) | 2024-01-18 | — | — | WO | disclosed |
| CN-110036007-A | PYRIDINE COMPOUND | 第一三共株式会社 | 2019-07-19 | — | — | CN | disclosed |
| CN-106999490-A | The glutamine enzyme inhibitor of crystal form | 卡利泰拉生物科技公司 | 2017-08-01 | — | — | CN | disclosed |
| US-8729269-B2 | Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy | WOCKHARDT LIMITED (IN) | 2014-05-20 | — | — | US | disclosed |
| EP-1664038-A2 | SUBSTITUTED PIPERIDINO PHENYLOXAZOLIDINONES HAVING ANTIMICRIOBIAL ACTIVITY WITH IMPROVED I IN VIVO /I EFFICACY | Wockhardt Limited (IN) | 2006-06-07 | — | — | EP | disclosed |
| US-20050143421-A1 | Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy | WOCKHARDT LIMITED | 2005-06-30 | — | — | US | disclosed |
| WO-2005054234-A2 | SUBSTITUTED PIPERIDINO PHENYLOXAZOLIDINONES HAVING ANTIMICRIOBIAL ACTIVITY WITH IMPROVED IN VIVO EFFICACY | WOCKHARDT LIMITED (IN) | 2005-06-16 | — | — | WO | disclosed |
| EP-1112252-A4 | KAPPA AGONIST COMPOUNDS AND PHARMACEUTICAL FORMULATIONS THEREOF | ADOLOR CORP (US) | 2004-07-14 | — | — | EP | disclosed |
| EP-1112252-A1 | KAPPA AGONIST COMPOUNDS AND PHARMACEUTICAL FORMULATIONS THEREOF | Adolor Corporation (US) | 2001-07-04 | — | — | EP | disclosed |
| WO-2000014065-A1 | KAPPA AGONIST COMPOUNDS AND PHARMACEUTICAL FORMULATIONS THEREOF | ADOLOR CORPORATION (US) | 2000-03-16 | — | — | WO | disclosed |
| EP-0436612-A4 | AMINO ACID TRANSPORT PROTEINS, AMINO ACID ANALOGUES, ASSAY APPARATUS, USES THEREOF FOR TREATMENT AND DIAGNOSIS OF CANCER | — | 1992-05-20 | — | — | EP | disclosed |
| EP-0436612-A1 | AMINO ACID TRANSPORT PROTEINS, AMINO ACID ANALOGUES, ASSAY APPARATUS, USES THEREOF FOR TREATMENT AND DIAGNOSIS OF CANCER | AUSTRALIAN COMMERCIAL RESEARCH & DEVELOPMENT LIMITED (AU) | 1991-07-17 | — | — | EP | disclosed |
| WO-1990003399-A1 | AMINO ACID TRANSPORT PROTEINS, AMINO ACID ANALOGUES, ASSAY APPARATUS, USES THEREOF FOR TREATMENT AND DIAGNOSIS OF CANCER | AUSTRALIAN COMMERCIAL RESEARCH & DEVELOPMENT LIMITED (AU) | 1990-04-05 | — | — | WO | disclosed |